OTCMKTS:LXXGF LexaGene (LXXGF) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free LXXGF Stock Alerts 0.08 -0.02 (-16.48%) (As of 02/21/2023) Add Compare Share Share Today's Range0.07▼0.1150-Day Range0.08▼0.0852-Week Range0.05▼0.25Volume1.42 million shsAverage Volume318,206 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get LexaGene alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About LexaGene Stock (OTCMKTS:LXXGF)LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.Read More LXXGF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LXXGF Stock News HeadlinesMay 31, 2023 | morningstar.comBeijing Bohui Innovation Biotechnology Group Co Ltd Class AApril 20, 2023 | theglobeandmail.comClosing Bell: Lexagene Holdings Inc down on Tuesday (LXG)April 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.February 24, 2023 | msn.comLexaGene Holdings files for bankruptcyFebruary 24, 2023 | finanznachrichten.deLexaGene Holdings Inc: LexaGene Files for Chapter 7 BankruptcyFebruary 24, 2023 | finance.yahoo.comLexaGene Files for Chapter 7 BankruptcyJanuary 18, 2023 | finance.yahoo.comLexaGene’s MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma CustomersDecember 16, 2022 | finance.yahoo.comBioPharma Engages LexaGene in Second Feasibility StudyApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.November 22, 2022 | finance.yahoo.comLexaGene Successfully Completes Statement of Work for BioPharma CompanyNovember 1, 2022 | finance.yahoo.comLexaGene Closes Secured Convertible Note TransactionNovember 1, 2022 | finance.yahoo.comLexaGene Closes Secured Convertible Note TransactionOctober 27, 2022 | finance.yahoo.comLexaGene Holdings Proposes to Amend Warrants TermsOctober 24, 2022 | finance.yahoo.comLexaGene Enters into Secured Convertible Note AgreementOctober 20, 2022 | finance.yahoo.comLarge Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology ValidationOctober 15, 2022 | seekingalpha.comLXXGF LexaGene Holdings Inc.October 13, 2022 | finance.yahoo.comLexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab SystemSeptember 1, 2022 | finance.yahoo.comLexaGene Announces MiQLab® System Sale to Veterinary Hospital in CaliforniaAugust 29, 2022 | finance.yahoo.comLexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be DeclaredAugust 26, 2022 | stockhouse.comLexaGene's MiQLab System Generates Leptospira Results in as Soon as 30 minutes using Isothermal ChemistryAugust 24, 2022 | finance.yahoo.comLexaGene’s MiQLab System Generates Leptospira Results in as Soon as 30 minutes using Isothermal ChemistryAugust 18, 2022 | stockhouse.comUniversity of Pennsylvania's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene's MiQLab SystemAugust 17, 2022 | finance.yahoo.comUniversity of Pennsylvania’s School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene’s MiQLab SystemAugust 10, 2022 | finance.yahoo.comLexaGene Reduces Time-to-Result by ~35%July 29, 2022 | finance.yahoo.comLexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to EmployeesJuly 27, 2022 | finance.yahoo.comLexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract InfectionsJuly 12, 2022 | finance.yahoo.comLexaGene Provides MCTO UpdateSee More Headlines Receive LXXGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:LXXGF CUSIPN/A CIK1450416 Webwww.lexagene.com Phone800 215 1824FaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. John F. Regan (Age 50)Founder, Chairman & CEO Comp: $371.68kMr. Jeffrey Mitchell (Age 51)CFO, Treasurer & Corp. Sec. Comp: $293.4kMr. Steven Armstrong (Age 57)Chief Operating Officer Comp: $234.32kMr. Allan John Fabbro (Age 65)VP of Corp. Devel. Nicole RidgedaleDirector of Corp. MarketingMr. Jay AdelaarVP of Capital MarketsMore ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors LXXGF Stock Analysis - Frequently Asked Questions How have LXXGF shares performed in 2024? LexaGene's stock was trading at 0.08 at the beginning of the year. Since then, LXXGF shares have decreased by 0.5% and is now trading at 0.08. View the best growth stocks for 2024 here. How do I buy shares of LexaGene? Shares of LXXGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LXXGF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
